HIMS Form 144 Filed for 2,637 Shares; Brokered Sale via Fidelity

Rhea-AI Filing Summary

Hims & Hers Health, Inc. filing a Form 144 notifies the proposed sale of 2,637 Class A shares by a holder whose shares were acquired on 09/15/2025 through restricted stock vesting and paid as compensation. The filing lists the broker as Fidelity Brokerage Services LLC and an approximate sale date of 09/17/2025, with an aggregate market value of $133,168.50. The issuer's total Class A shares outstanding are stated as 217,641,958, indicating the proposed sale represents a very small fraction of outstanding stock. The filing also discloses six prior Class A sales by the same person between 06/17/2025 and 08/25/2025, each of roughly 2,571–2,572 shares with gross proceeds ranging from $114,486.63 to $153,677.00. The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information.

Positive

• Compliance: The filer discloses acquisition date, nature of acquisition, broker, and prior dispositions as required under Rule 144
• Transparency: Recent sales in the past three months are fully listed with dates and gross proceeds

Negative

• Insider selling: The holder has executed multiple small sales in recent months which may be viewed unfavorably by some investors

Insights

Securities Compliance Analyst

TL;DR: Routine insider sale notice tied to restricted stock vesting; size is immaterial relative to outstanding shares.

The Form 144 documents a proposed sale of 2,637 Class A shares acquired via restricted stock vesting and paid as compensation on 09/15/2025, with an intended brokered sale on or about 09/17/2025 through Fidelity. The filing properly aggregates recent dispositions by the same holder over the prior three months, showing six prior small sales totaling 15,351 shares and gross proceeds reported per transaction. From a compliance perspective, the filing meets Rule 144 disclosure requirements by identifying acquisition date, nature of acquisition, payment method, broker, and prior sales. There is an explicit seller representation about lack of undisclosed material adverse information, consistent with required certifications.

Equity Analyst

TL;DR: Insider sales are small relative to the float and likely not material to shareholders' valuation.

The proposed 2,637-share sale equals a negligible portion of the stated 217,641,958 Class A shares outstanding. The aggregated recent sales disclosed (six transactions of ~2,571–2,572 shares each) suggest routine monetization of vested compensation rather than a concentrated liquidation. The disclosed aggregate market values per transaction vary, indicating sales executed at differing market prices. Based solely on the filing, there is no disclosure of material operational or financial developments tied to these sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2637	133168.50	217641958	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/15/2025	Restricted Stock Vesting	Issuer			2637	09/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	2572	153677.00
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/30/2025	2572	129886.00
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/14/2025	2572	122993.04
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/28/2025	2572	150976.40
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/11/2025	2572	132818.08
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/25/2025	2571	114486.63

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for HIMS cover?

The Form 144 covers 2,637 Class A shares proposed for sale, acquired via restricted stock vesting on 09/15/2025.

When is the proposed sale date and which broker is listed?

Approximate sale date is 09/17/2025 and the broker is listed as Fidelity Brokerage Services LLC.

How large is this sale relative to HIMS outstanding shares?

Outstanding Class A shares are 217,641,958, so 2,637 shares represent a very small fraction of the outstanding stock.

Has the seller made recent sales of HIMS stock?

Yes: six prior Class A sales between 06/17/2025 and 08/25/2025, each ~2,571–2,572 shares, with gross proceeds reported for each transaction.

How were the shares acquired and how was payment made?

The shares were acquired through restricted stock vesting on 09/15/2025 and payment is listed as compensation.